The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...
Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...
Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced additional results from the successful VERIFI study of its next-generation pancreatic cancer test, ...
New research from Mayo Clinic finds that the presence of a specific genetic mutation — KRAS circulating tumor DNA (ctDNA) — ...
Medical Xpress on MSN5d
Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer: StudyAdding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...
A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.
Midland Reporter-Telegram on MSN1d
Understanding colorectal cancer: Risks, screening and genetic factorsColorectal cancer affects 1 in 24 men and 1 in 26 women. Learn about risks, screening, and genetic factors like Lynch ...
From increasing fibre intake to staying hydrated and exercising regularly, know healthy diet and lifestyle tweaks to prevent ...
More than 700 oncologists, cancer researchers and advocates will converge on the Crescent City this week as part of the 2025 NeauxCancer Conference. The event got its start four years ago by the ...
More and more people are being diagnosed with pancreatic cancer. This disease is insidious, often only making itself known in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback